Richard Scott Struthers

Insider Reports History

Location
San Diego, CA
Signature
/s/ Tobin Schilke, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Scott Struthers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 661K $19.4M $29.40 26 Sep 2025 By Family Trust 1
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 320K $9.41M $29.40 26 Sep 2025 Direct
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 106K $4.77M $45.00 26 Sep 2025 By Family Trust 2
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 110K $3.23M $29.40 26 Sep 2025 By Family Trust 3
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 100K $2.94M $29.40 26 Sep 2025 By Family Trust 4
Crinetics Pharmaceuticals, Inc. President & CEO, Director Common Stock 1K $29.4K $29.40 26 Sep 2025 By Spouse
Crinetics Pharmaceuticals, Inc. President & CEO, Director Stock Option (Right to Buy) 0 02 Apr 2025 Direct

Insider Reports Filed by Richard Scott Struthers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRNX Crinetics Pharmaceuticals, Inc. 26 Sep 2025 1 -$180K 4 President & CEO, Director 30 Sep 2025, 16:42
CRNX Crinetics Pharmaceuticals, Inc. 14 May 2025 2 $0 4 President & CEO, Director 16 May 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 02 Apr 2025 2 $155K 4 President & CEO, Director 04 Apr 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 19 Mar 2025 2 -$593K 4 President & CEO, Director 21 Mar 2025, 18:31
CRNX Crinetics Pharmaceuticals, Inc. 20 Feb 2025 2 $0 4 President & CEO, Director 24 Feb 2025, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 02 Dec 2024 1 -$576K 4 President & CEO, Director 04 Dec 2024, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 08 May 2024 3 -$4.31M 4 President & CEO, Director 10 May 2024, 16:57
CRNX Crinetics Pharmaceuticals, Inc. 18 Apr 2024 1 $0 4 President & CEO, Director 22 Apr 2024, 17:23
CRNX Crinetics Pharmaceuticals, Inc. 15 Apr 2024 2 $38.2K 4 President & CEO, Director 17 Apr 2024, 16:30
CRNX Crinetics Pharmaceuticals, Inc. 04 Apr 2024 3 -$1.63M 4 President & CEO, Director 08 Apr 2024, 17:09
CRNX Crinetics Pharmaceuticals, Inc. 18 Mar 2024 1 -$484K 4 President & CEO, Director 20 Mar 2024, 18:31
CRNX Crinetics Pharmaceuticals, Inc. 04 Mar 2024 2 $0 4 President & CEO, Director 06 Mar 2024, 20:01
CRNX Crinetics Pharmaceuticals, Inc. 12 Feb 2024 4 $0 4 President & CEO, Director 14 Feb 2024, 16:28
CRNX Crinetics Pharmaceuticals, Inc. 09 Nov 2023 2 $95.5K 4 President & CEO, Director 13 Nov 2023, 16:33
CRNX Crinetics Pharmaceuticals, Inc. 02 Nov 2023 6 -$4.26M 4 President & CEO, Director 06 Nov 2023, 18:02
CRNX Crinetics Pharmaceuticals, Inc. 14 Aug 2023 2 $19.1K 4 President & CEO, Director 16 Aug 2023, 17:30
CRNX Crinetics Pharmaceuticals, Inc. 11 Jul 2023 3 -$1.01M 4 President & CEO, Director 13 Jul 2023, 16:56
CRNX Crinetics Pharmaceuticals, Inc. 16 Jun 2023 1 -$1.04M 4 President & CEO, Director 21 Jun 2023, 17:27
CRNX Crinetics Pharmaceuticals, Inc. 16 Mar 2023 1 -$79.2K 4 President & CEO, Director 17 Mar 2023, 17:10
CRNX Crinetics Pharmaceuticals, Inc. 01 Mar 2023 2 $0 4 President & CEO, Director 03 Mar 2023, 15:31
CRNX Crinetics Pharmaceuticals, Inc. 12 Oct 2022 2 $21.2K 4 President & CEO, Director 14 Oct 2022, 16:55
CRNX Crinetics Pharmaceuticals, Inc. 13 Apr 2022 3 -$3.72M 4 President & CEO, Director 15 Apr 2022, 18:00
CRNX Crinetics Pharmaceuticals, Inc. 05 Apr 2022 1 -$541K 4 President & CEO, Director 07 Apr 2022, 17:58
CRNX Crinetics Pharmaceuticals, Inc. 28 Feb 2022 2 $0 4 President & CEO, Director 02 Mar 2022, 20:00
CRNX Crinetics Pharmaceuticals, Inc. 07 Sep 2021 3 -$750K 4 President & CEO, Director 09 Sep 2021, 17:00